Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06995924 · ClinicalTrials.gov registry record · NA
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
A NA study of Stage III Colorectal Cancer AJCC v8 and Stage II Colorectal Cancer AJCC v8, sponsored by Fred Hutchinson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT06995924: Recruiting NA study of Stage III Colorectal Cancer AJCC v8 and Stage II Colorectal Cancer AJCC v8, sponsored by Fred Hutchinson Cancer Center.
NCT06995924 is a NA study of Stage III Colorectal Cancer AJCC v8 and Stage II Colorectal Cancer AJCC v8 that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 75 participants, below the 124-participant average among 17 other Stage III Colorectal Cancer AJCC v8 trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06995924, a NA study of Stage III Colorectal Cancer AJCC v8 and Stage II Colorectal Cancer AJCC v8, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment surveillance is critical to detect recurrence early, yet many CRC survivors do not receive recommended surveillance care. Surveillance is a complex process that includes laboratory tests, cross-sectional imaging, and endoscopic procedures. Patient navigation services, interactive web education, or a combination of both may improve surveillance care for patients with stage I-III colorectal cancer.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Educational Intervention
- OTHER Electronic Health Record Review
- OTHER Internet-Based Intervention
- BEHAVIORAL Patient Navigation
Study Locations (2)
Washington
- Benaroya Research Institute at Virginia Mason - Seattle
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT06995924 shows while recruiting
NCT06995924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 124-participant average among 17 other Stage III Colorectal Cancer AJCC v8 trials with a reported enrollment target (40% lower).
The record links to 3 conditions, with Stage III Colorectal Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Survey Administration is the first listed.
NCT06995924 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06995924 about?
NCT06995924 is a clinical study titled "Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education". This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment...
What is the current status of trial NCT06995924?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-11-17. Estimated completion is 2027-03-31.
What conditions does trial NCT06995924 study?
This clinical trial studies the following conditions: Stage III Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage I Colorectal Cancer AJCC v8.
What interventions are being tested in trial NCT06995924?
The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Internet-Based Intervention (OTHER), Patient Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06995924?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06995924 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage III Colorectal Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06995924's enrollment target sits among peer trials
75 6th of 17 higher than 12 of 17 other Stage III Colorectal Cancer AJCC v8 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage III Colorectal Cancer AJCC v8 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
RECRUITING · NA
-
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
RECRUITING · NA
-
Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer
ACTIVE NOT RECRUITING · NA
-
Diet Education Program for Stage I-IV Colorectal Cancer Survivors
COMPLETED · NA
-
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
RECRUITING · Phase 1
-
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI